Patents by Inventor Elise Burmeister-Getz

Elise Burmeister-Getz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED IL-4 MUTEIN RECEPTOR ANTAGONISTS
    Publication number: 20110183920
    Abstract: This invention relates to modified IL-4 mutein receptor antagonists comprising an IL-4 mutein receptor antagonist coupled to polyethylene glycol. Related formulations and dosages and methods of administration thereof for therapeutic purposes are also provided. These modified IL-4 mutein receptor antagonists, compositions and methods provide a treatment option for those individuals afflicted with a respiratory disorder such as asthma by inhibiting IL-4 and IL-13-mediated airway hyperresponsiveness and eosinophilia. More particularly, these antagonists have an increased duration of effect versus unmodified IL-4RA by virtue of a greater plasma half-life.
    Type: Application
    Filed: August 25, 2010
    Publication date: July 28, 2011
    Applicant: AEROVANCE, INC.
    Inventors: Clark Pan, Steve Roczniak, Jeffrey Michael Greve, Stephanie L. Yung, Malinda Longphre, Teresa Mo-Fun Wong, Adrian Tomkinson, David Boisvert, Elise Burmeister-Getz, Kathy Delaria
  • Modified IL-4 mutein receptor antagonists
    Patent number: 7785580
    Abstract: This invention relates to modified IL-4 mutein receptor antagonists comprising an IL-4 mutein receptor antagonist coupled to polyethylene glycol. Related formulations and dosages and methods of administration thereof for therapeutic purposes are also provided. These modified IL-4 mutein receptor antagonists, compositions and methods provide a treatment option for those individuals afflicted with a respiratory disorder such as asthma by inhibiting IL-4 and IL-13-mediated airway hyperresponsiveness and eosinophilia. More particularly, these antagonists have an increased duration of effect versus unmodified IL-4RA by virtue of a greater plasma half-life.
    Type: Grant
    Filed: November 14, 2007
    Date of Patent: August 31, 2010
    Assignee: Aerovance, Inc.
    Inventors: Clark Pan, Steve Roczniak, Jeffrey Michael Greve, Stephanie L. Yung, Malinda Longphre, Teresa Mo-Fun Wong, Adrian Tomkinson, David Boisvert, Elise Burmeister-Getz, Kathy Delaria